A scientific team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD). The blood test ...
After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
A new COPD diagnostic framework incorporating chest CT imaging and symptom assessment reclassified patients in two large cohorts, identifying at-risk individuals missed by traditional spirometry. The ...
An experimental blood test could one day help identify people most likely to develop severe lung problems like COPD. The test reviews a panel of 32 proteins in blood that best predict people most ...
Considering a risk score generated from multiple genetic variants linked to chronic obstructive pulmonary disease (COPD) caught undiagnosed cases of the disease better than conventional risk factors ...
Leveraging lung cancer screening can improve chronic obstructive pulmonary disease detection and intervention in underserved populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results